Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: A predictive model from microfilaraemia and antigenaemia prevalence surveys
The Global Programme to Eliminate Lymphatic Filariasis has encouraged countries to follow a set of guidelines to help them assess the need for mass drug administration and evaluate its progress. Papua New Guinea (PNG) is one of the highest priority countries in the Western Pacific for lymphatic filariasis and the site of extensive research on lymphatic filariasis and surveys of its prevalence. However, different diagnostic tests have been used and thresholds for each test are unclear.
|Collections||ANU Research Publications|
|Source:||Tropical Medicine and Health|
|Access Rights:||Open Access|
|01_Berg+Soto_Combining_different_diagnostic_2018.pdf||2.2 MB||Adobe PDF|
This item is licensed under a Creative Commons License